Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
Date:8/3/2013

New York, New York (PRWEB) August 03, 2013

Lawsuits filed in the wake of the 2010 DePuy ASR recall (http://www.depuy-asr-hip-recall.com/) continue to move forward in courts around the country. On July 26th, DePuy Orthopaedics moved for summary judgment in a bellwether case scheduled to go to trial October 1st in a consolidated proceeding now underway in California Superior Court. According to court documents, the Plaintiff has until August 30th to file an opposition to the motion. Judge Richard A. Kramer, who is overseeing the California DePuy ASR recall litigation, has scheduled a hearing on dispositive motions for September 13, 2013. (DePuy ASR HIP System Cases, No. CJC-10-004649; Calif. Super. Ct., San Francisco Cty.)

“Our Firm is pleased to see the various litigations involving the DePuy ASR recall moving forward. We look forward to the start of bellwether trials this fall in both the federal multidistrict litigation underway in Ohio, and in the California state proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Recall
DePuy Orthopaedics recalled its metal-on-metal line of ASR hip implants in August 2010. According to the U.S. Food & Drug Administration (FDA), the recall was issued after data from a United Kingdom joint registry indicated that the 5 year revision rate associated with the devices was approximately 13 percent. Since then, more than 11,000 DePuy ASR lawsuits have been filed in courts throughout the country, most of which are pending in a federal multidistrict litigation underway in U.S. District Court, Northern District of Ohio. The first bellwether trial in that proceeding is scheduled to begin on September 9, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

Elsewhere, two DePuy ASR lawsuits have already gone to trial in state court. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the hip implant was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

Following the announcement of the DePuy ASR recall, the FDA embarked on a safety review of metal-on-metal hips. In January the agency urged patients with such devices to undergo metal ion blood tests if they experienced any symptoms that would signify a failing hip implant. The FDA has also proposed a new rule which would subject such devices to greater regulatory oversight.*

Individuals who have experienced metallosis, premature device failure or other complications allegedly associated with the DePuy ASR recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. Read More about filing a DePuy ASR lawsuit at Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241770.htm#2

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-recall/prweb10994385.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy Pinnacle Hip Litigation
2. US Drug Watchdog Now Urges All DePuy ASR Recalled Metal Hip Implant Recipients In The Remaining States To Call Them Immediately If They Have Not Yet Been Identified
3. US Drug Watchdog Now Warns Recipients Of A Recalled DePuy ASR Hip Implant About Statute Of Limitations Deadline To Get Identified And Urges Recipients To Call Them
4. California Judge Allows Plaintiffs in DePuy ASR Litigation to Combine DePuy Pinnacle Claims, Parker Waichman LLP Notes
5. DePuy Hip Replacement Lawsuit News: California Judge Allows DePuy ASR Lawsuit Plaintiffs to Add Pinnacle Hip Claims
6. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test That Should Reveal A Premature Failure
7. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them For The Name Of A Special Blood Test That Will Determine A Premature Failure
8. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them About A Specific Blood Test Designed To Determine A Failure-Nationwide
9. DePuy Pinnacle Lawsuit Filed by Wright & Schulte on Behalf of Utah Man Who Developed Serious Injuries Allegedly Due to the DePuy Pinnacle Metal on Metal Hip Replacement
10. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Canadian Report That Shows Some Metal-on-Metal Hip Recipients More Likely to Need Revision Surgery
11. DePuy ASR Hip Replacement Lawsuits Moving Along in California, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... From March 4 through ... Dermatology Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. ... the condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company ...
(Date:2/11/2016)... Diego, CA (PRWEB) , ... February 11, 2016 , ... ... which was held in San Diego, CA, on February 6th & 7th, 2016 according ... combine for those who were not invited to the NFL’s combine in Indianapolis,” says ...
(Date:2/11/2016)... ... 11, 2016 , ... The book, “Computers Should Just Work!”, provides a basic, ... your IT consultant before signing a contract and how to spot an incompetent or ... relying heavily on e-mail and technology, it’s more important than ever to make sure ...
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of ... Round Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian ... Billy Cundiff. , “We are honored to support a promising young investigator from Dr. ...
(Date:2/10/2016)... Culver City, California (PRWEB) , ... February 10, ... ... Molecular Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will ... The theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... --> --> This press release is ... --> Japan .  --> A separate press release has ... Shire continues to strengthen its presence ... Shire continues to strengthen its presence in ... continues to strengthen its presence in ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... YORK , Feb. 10, 2016 Immune ... biopharmaceutical company, announced today that it has filed a ... Leukemia and other cancers. --> ... treating cancer by administration of Ceplene (histamine dihydrochloride) in ... provides methods of predicting the efficacy of Ceplene and ...
Breaking Medicine Technology: